Camlin Fine Sciences Receives ₹5.47 Crore Income Tax Demand Notice for AY24
Camlin Fine Sciences received an Income Tax demand notice for AY24 for ₹5.47 crore due to an Arm's Length Price adjustment. The company believes there is no financial or operational impact and plans to appeal the order. The notice was received on April 10, 2026.
While the company states there is no immediate financial or operational impact and plans to appeal, a tax demand of ₹5.47 crore can potentially impact cash flows and requires significant legal and administrative effort to contest.
The company has received a significant tax demand notice, which is generally a negative development.
Camlin Fine Sciences Limited has received a notice of demand under section 156 of the Income-Tax Act, 1961, from the Assessment Unit, Income Tax Department. This notice pertains to an Assessment Order for the Assessment Year 2023-24, directing the company to deposit a sum of ₹5,46,98,560 (approximately ₹5.47 crore) within 30 days. The demand arises from an Arm's Length Price adjustment concerning international and domestic transactions with associated enterprises. The company has stated that this order will not have any impact on its financial, operational, or other activities. Camlin Fine Sciences is currently examining the order and is in the process of filing an appeal against it. The company received this communication on April 10, 2026.
What to do with a filing like this
Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.